The Zephyr BioHarness 3.0 (BH3) is a popular wearable system specifically designed for training optimization of professional athletes. BH3 provides the electrocardiogram (ECG BH3) and the heart-rate signal (HRSBH3). Aim of this study is to evaluate the reliability of HRSBH3 to assess its clinical applicability to the general population for cardiac-risk evaluations. Data were acquired from 10 healthy subjects (age: 34±17 years) during a 5-minutes rest. Since the tachogram represents the standard signal for studying the heart rate (HR) and its variability, ECG BH3 was elaborated in order to get the tachogram (HRSTG). HRSBH3 and HRSTG were compared in terms of mean HR (MHR, bpm), HR standard deviation (HRSD, bpm) and HRSD error (bpm). HRSBH3 and HRSTG provided comparable MHR (73.07±15.53 bpm vs 72.86±15.57 bpm, respectively) while HRSD by HRSBH3 was significantly lower than HRSD by HRS TG (4.51 ±2.29 bpm vs 5.63±2.99 bpm, respectively; P=0.0043). HRSD error was significantly greater than zero (0.20–3.00 bpm; P=0.0043); moreover, it was strongly correlated to HRSD by HRS TG (p=0.82, P=0.0036). Thus, HRS BH3 is appropriate only for sport applications based on MHR estimations, but not to clinical evaluations based on HRV measurements. (Author/publisher)
Abstract